Interaction Between HLA-DR2 and Abnormal Brain MRI in Optic neuritis and Early MS
Neurol 54:1859-1861, Hauser,S.L.,et al, 2000
Multiple Sclerosis
NEJM 343:938-952, Noseworthy,J.H. et al, 2000
Morvans Syndrome Associated With Voltage-Gated K+ Channel Antibodies
Neurol 54:771-772, Barber,P.A., et al, 2000
Behcet's Disease
NEJM 341:1284-1291, Sakane,T.,et al, 1999
Ion Channel Diseases:Episodic Disorders of the Nervous System
Semin Neurol 19:363-369, Ptacek,L.J., 1999
Elevated Tissue Plasminogen Activator Antigen and Stroke Risk,The Stroke Prevention in Young Women Study
Stroke 30:7-11, Macko,R.F.,et al, 1999
Ion Channels and Neurological Disease:DNA Based Diagnosis is Now Possible,and Ion Channels May be Important in Common Paroxysmal Disorders
JNNP 65:427-431, Hanna,M.G.,et al, 1998
Diagnostic Aspects of Narcolepsy
Neurol 50:S2-S7, Aldrich,M.S., 1998
Optic Neuritis, Prognosis for Multiple Sclerosis from MRI, CSF, and HLA Findings
Neurol 50:708-714, Soderstrom,M.,et al, 1998
Neurological Channelopathies, Dysfunctional Ion Channels May Cause Many Neurological Diseases
BMJ 316:1104-1105, Rose,M.R., 1998
Progression of Ischaemic Stroke and Excitotoxic Aminoacids
Lancet 349:79-83, Castillo,J.,et al, 1997
HLA Typing in Acute Optic Neuritis, Relation to MS & Magnetic Resonance Imaging Findings
Arch Neurol 54:76-80, Frederiksen,J.L.,et al, 1997
Myasthenia Gravis and Sarcoidosis:Report of 2 Cases
Eur Neurol 36:326-327, DeBleecker,J.,et al, 1996
Clinical and Subclinical Neurological Involvement in Children of Conjugal Multiple Sclerosis Patients
Multiple Sclerosis 1:170-172, Constantinescu,C.S.,et al, 1996
Clinical Experience with Excitatory Amino Acid Antagonist Drugs
Stroke 26:503-513, Muir,K.W.&Lees,K.R., 1995
Fisher Syndrome after Campylobacter Jejuni Enteritis:Human Leukocyte Antigen and the Bacterial Serotype
J Pediatr 126:55-57, Yuki,N.,et al, 1995
Bilateral Simultaneous Optic Neuropathy in Adults:Clinical, Imaging, Serological, and Genetic Studies
JNNP 58:70-74, Morrissey,S.P.,et al, 1995
Acquired Neuromyotonia:Evidence for Autoantibodies Directed Against K+Channels of Peripheral Nerves
Ann Neurol 38:714-722, 7011995., Shillito,P.,et al, 1995
Clinical Correlates of Secondary Meningitis in HIV-Infected Adults
Arch Int Med 155:2231-2237, Friedmann,P.D.,et al, 1995
Crptococcal Disease of the CNS in Immunocompetent Hosts: Influence of Cryptococcal Variety on Clinical Manifestations and Outcome
Clin Infect Dis 20:611-616, Mitchell,D.H.,et al, 1995
Excitatory Amino Acids as a Final Common Pathway for Neurologic Disorders
NEJM 330:613-622, Lipton,S.A.&Rosenberg,P.A., 1994
A Controlled Trial of Riluzole in Amyotrophic Lateral Sclerosis
NEJM 330:585-591, Bensimon,G.,et al, 1994
Clinical Usefulness of CSF Bacterial Antigen Studies
J Pediatr 125:235-238, Maxson,S.,et al, 1994
Prophylactic Neuroprotection for Cerebral Ischemia
Stroke 25:1075-1080, Fisher,M.,et al, 1994
The Ischemic Penumbra, Injury Thresholds, and the Therapeutic Window for Acute Stroke
Ann Neurol 36:553-554, 5571994., Ginsberg,M.D.&Pulsinelli,W.A., 1994
Evolving Toward Effective Therapy for Acute Ischemic Stroke
JAMA 270:360-364, Fisher,M.&Bogousslavsky,J., 1993
Human Leukocyte Antigens in Fisher's Syndrome
Ann Neurol 33:655-657, Yuki,N.,et al, 1993
Idiopathic Childhoos Stroke is Associated with Human Leukocyte Antigen (HLA) -B51
Ann Neurol 31:675-677, Mintz,M.,et al, 1992
Do NMDA Antagonists Prevent Neuronal Injury? Yes
ARch Neurol 49:418-420, Albers,G.W.,et al, 1992
Do NMDA Antagonists Prevent Neuronal Injury? No
Arch Neurol 49:420-421, Buchan,A.M., 1992
Recurrent Transverse Myelitis, Myasthenia Gravis, and Autoantibodies
Ann Neurol 32:407-409, Lindsey,J.W.,et al, 1992
Conjugal Multiple Sclerosis:Immunogenetic Characterization and Analysis of T-and B-Cell Reactivity to Myelin Proteins
Neurol 42:577-582, Frederickson,S.,et al, 1992
Central-Nervous-System Demyelination after Immunisation with Recombinant Hepatitis B Vaccine
Lancet 338:1174-1175, Herroelen,L.,et al, 1991
Central Nervous System Abnormalities in Lyme Neuroborreliosis
Neurol 41:1571-1582, Halperin,J.J.,et al, 1991
Localization of Idiopathic Generalized Epilepsy on Chromosome 6p in Families of Juvenile Myoclonic epilepsy patients
Neurol 41:1651-1655, Durner,M.,et al, 1991
Conjugal Multiple Sclerosis:A Clinical and Laboratory Study
Neurol 41:1320-1321, Finelli,P.F., 1991
Clinical Follow-Up and Immunogenetic Studies of 32 Patients with Eosinophilia-Myalgia Syndrome
Lancet 337:1071-1074, Kaufman,L.D.,et al, 1991
N-Methyl-D-Aspartate Antagonists in the Treatment of Parkinson's Disease
Arch Neurol 48:977-981, Greenamyre,J.T.&O'Brien,C.F., 1991
Tissue Plasminogen Activator Plus Glutamate Antagonist Improves Outcome after Embolic Stroke
Arch Neurol 48:1235-1238, Zivin,J.A.&Mazzarella,V., 1991
The Bioloigcal Basis for the Treatment of Acute Stroke
Neurol 41:1867-1873, Scheinberg,P., 1991
Narcolspey
NEJM 323:389-394, Aldrich,M.S., 1990
A Long-Term Prospective Study of Optic Neuritis:Evaluation of Risk Factors
Ann Neurol 27:386-393, Sandberg-Wollheim,M.,et al, 1990
Risk Factors for Multiple Sclerosis:Race or Place? Editorial
JNNP 53:821-823, 903, 906990., Compston,A., 1990
Characteristics of Narcolepsy in Preteenaged Children
Pediatrics 85:205-209, Kotalgal,S.,et al, 1990
Familial Patterns of Narcolepsy
lancet 2:1376-1379, Guilleminault,C.,et al, 1989
Narcolepsy Associated with Lesions of the Diencephalon
Neurol 39:1505-1508, Aldrich,M.S.&Naylor,M.W., 1989
Genetic Factors in Myasthenia Gravis:A Family Study
Neurol 38:38-42, Kerzin-Storrar,L.,et al, 1988
Narcolepsy & Immunity
BMJ 292:359-360, Parkes,J.D.,et al, 1986
Rapid Diagnosis of Tuberculous Meningitis by Latex Particle Agglutination
Lancet 2:1229-1254, Krambovitis,E.,et al, 1984
Multiple Sclerosis, (First of Two Parts)
NEJM 307:1183-1188, 1982, McFarlin,D.E.,et al, 1982